Sirukumab improves rheumatoid arthritis symptoms in phase II trial
The investigational drug sirukumab significantly improved signs and symptoms of rheumatoid arthritis in a
Rheumatology (Greek ρεύμα, rheuma, river) is a sub-specialty in internal medicine and pediatrics, devoted to diagnosis and therapyof rheumatic diseases. Clinicians who specialize in rheumatology are called rheumatologists. Rheumatologists deal mainly with clinical problems involving joints, soft tissues, autoimmune diseases, vasculitis, and heritable connective tissue disorders.